This country profile provides an overview of Somalia’s progress in reaching those in need of mass NTD treatment based on 2017 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Download country profiles

Treatment coverage

Elephantiasis
N/A
Blinding trachoma
N/A
Intestinal worms
31%
Bilharzia
51%
River blindness
N/A
0.72 million people received treatment in Somalia in 2017 1.82 million people did not receive treatment in Somalia in 2017

Priorities for progress in Somalia

  • Somalia has made great progress in the last two years.
  • It should work to further build a preventive chemotherapy programme for bilharzia and intestinal worms, with systematic annual high coverage implementation, in all risk groups, as recommended by WHO.
  • Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.

Elephantiasis

Somalia does not require mass treatment for elephantiasis.

Blinding trachoma

Somalia has not been mapped for trachoma and the status unknown.

Intestinal worms

Treatment coverage increased from 0% in 2016 to 31% in 2017.

Pre-sch and school-aged children needing treatment
1.45m
Pre-school and school-aged children receiving treatment
0.45m

Bilharzia

Treatment coverage increased from 0% in 2016 to 51% in 2017.

School-aged children needing treatment
1.38m
School-aged children receiving treatment
0.71m

River blindness

Somalia does not require mass treatment for river blindness.